At West Rock Wellness, we have a deep reverence and respect for the power of psychedelic medicines and the many indigenous traditions that have cultivated expertise and tradition in their use over millenia. Acknowledging their complexity, we view psychedelic medicines, including ketamine, psilocybin, MDMA, mescaline, and ayahuasca, from an interdisciplinary perspective. For instance, we consider how these medicines impact us on biological, psychological, emotional, and spiritual levels. We also understand the potential power of these experiences and how experiences are shaped by an individual’s mindset and physical surroundings. As a result, we offer a highly supportive and aesthetically pleasing environment for psychedelic therapy and customize treatment to each individual (i.e. dosage, frequency of sessions, amount of support).
​
West Rock Wellness currently offers ketamine-assisted psychotherapy (KAP) as well as psychedelic integration services. Ketamine-assisted psychotherapy refers to the supported use of ketamine as part of a broader course of therapy and treatment. In this paradigm, ketamine not only produces beneficial neurobiological changes (e.g. neuroplasticity), but also engenders an altered state of consciousness which can facilitate therapeutic growth and healing. Critically, this occurs within the context of a therapeutic relationship and safe, comfortable environment here at West Rock Wellness.
​
In approaching this work, we humbly seek to facilitate clients’ own healing processes and recognize the need for different levels of support before, during, and after each experience. Given the richness and depth of these experiences, we believe that for many clients, the full potential of psychedelic medicines is unlocked when utilized in the context of psychotherapy and integrated into a broader approach to wellness and mental health.
​
As the evidence base for psychedelic therapies and KAP continue to emerge, we endeavor to incorporate research findings into clinical practice, while also helping generate evidence on novel treatment approaches to guide best practices.​​
KETAMINE-ASSISTED PSYCHOTHERAPY
What to Expect
​
​
All clients interested in KAP will first undergo a comprehensive psychiatric evaluation to determine if KAP is a safe and prudent treatment option. If appropriate, we will work with each client to tailor a course of KAP that meets their needs. In order to support each client's unique needs and also promote accessibility of this treatment, we offer KAP through several treatment models: individual treatment with 1 or 2 therapists, and in small groups (note: the first dosing session is always individual). We also offer KAP through both sublingual and intramuscular routes of administration. All of these elements affect the nature and length of the ketamine experience, as well as cost. All KAP models involve preparatory psychotherapy sessions prior to dosing and integration sessions after dosing. Critically, these sessions help ensure safety and that clients get the most benefit out of each treatment session.
​
Our staff will be happy to discuss KAP options and pricing with you.
​
For more information about ketamine and KAP, please see:
​
Training and Experience
in Psychedelic Therapy
Our clinical team is uniquely trained across a variety of psychedelic-assisted therapy modalities. Drs Sloshower, Kilpatrick, and Hokanson have all completed training in psilocybin-assisted therapy at Yale University where they have served as investigators and therapists in multiple trials of psilocybin-assisted therapy. They have also all completed training in MDMA-assisted psychotherapy with the Multidisciplinary Association for Psychedelic Studies (MAPS).
Dr Sloshower and his colleagues developed and published The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame). Drs Sloshower and Hokanson received further training in psilocybin therapy from the Usona Institute, where Dr Sloshower served as a trainer. Dr Sloshower has experience treating patients with ketamine in both hospital and clinic settings. His approach to ketamine treatment is informed by his experience providing other psychedelic therapies, which involve harnessing the power of altered states of consciousness to facilitate therapeutic work when combined with psychotherapy.​​​
Testimonials
I came to Dr. Sloshower during the absolute darkest period of my life. At that time my family and I had tried multiple other methods of therapy with several different providers and nothing seemed to work. I agreed to try ketamine therapy with Dr. Sloshower, thinking I would just tick the box of something else I tried and move on. I could not have been more wrong. My sessions with Dr. Sloshower rapidly changed my life for the better. Ingesting the ketamine and following Dr. Sloshower’s guidance, I was able to reach a different level of consciousness, in which I viewed the world from an entirely different lens. I learned so many repressed truths about myself and who I want to be. I was also able to put problems and challenges in perspective, understanding that the things which I viewed as critical for a happy life enforced a lot of my bad habits and drove my depression. Since my sessions with Dr. Sloshower, I have begun graduate school at a top 10 U.S. institution, rekindled damaged relationships, and ultimately found the drive to push forward and the zest for life I thought was forever gone. Dr. Sloshower also frequently checks in on me, unlike all of my other therapists. It is very clear that he cares about my wellbeing. I simply wish that this treatment was accessible to everyone and more so, that everyone could experience it with Dr. Sloshower.’
“
Selected Publications and Talks
-
Sloshower, J, et al. (2023). Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial. Journal of Psychopharmacology;0(0). https://doi.org/10.1177/02698811231154852
​
-
Sloshower, J. “The Promise and Perils of Psychedelic Therapy.” The Tom Ficklin Show. WNHH. 17 March 2023.
​
-
Sloshower, J., Guss, J., et al. (2020). Psilocybin-Assisted Therapy of Major Depressive Disorder Using Acceptance and Commitment Therapy as a Therapeutic Frame. Journal of Contextual Behavioral Science. 15:12-19.
​
-
Guss, J., Krause, R. & Sloshower, J. (2020, August 13). The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame). https://psyarxiv.com/u6v9y/
​
-
Sloshower, J. (2018). “Integrating Psychedelic Medicines and Psychiatry: Theory and Methods of a Model Clinic.” Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives. Eds Labate, Beatriz and Cavnar, Clancy. Springer.Sloshower, J. (2017). “Is Psychiatry Ready for the Psychedelic Healing Paradigm?”
​
-
Chacruna online magazine. http://chacruna.net/is-psychiatry-ready-for-psychedelic-healing
Psychedelic substances and plants are critical tools that point us toward a more integrated and holistic way of conceptualizing human suffering and, accordingly, its treatment. Their lessons argue against narrow approaches or those based on fear, avoidance, and passivity. Rather, they help bring into focus our profound and nearly incomprehensible existential condition as impermanent beings intimately connected with all other forms of life, matter, and energy.”
– from Sloshower (2018). “Integrating Psychedelic Medicines and Psychiatry:
Theory and Methods of a Model Clinic.”
“